Atlas Trials

Recurrent/Advanced Gastric Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent/Advanced Gastric Cancer

RecordFirmDate
Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression (NCT05512182)Yonsei University2022-09-15

Track Recurrent/Advanced Gastric Cancer automatically

Every clearance here is in the API, with alerts when new ones post.